TransMedics Group, Inc.

NasdaqGM:TMDX

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🩺 Medical Instruments

Location

United States

Market Cap

USD 4.34 B

Share Price

USD 127.26

Avg Daily Volume

1,029,087

Change (1 day)

11.14%

Change (1 year)

-21.87%

Change (YTD)

104.11%

TransMedics Group, Inc. Accounts Payable for the year ending August 13, 2025: N/A

TransMedics Group, Inc. Accounts Payable is NA for the year ending August 13, 2025. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Competitors

Roche Holding AG

USD 317.50

RO.SW

-1.30 -0.41%

Abbott Laboratories

USD 131.36

ABT

-2.92 -2.17%

Thermo Fisher Scientific Inc.

USD 462.39

TMO

+1.67 0.36%

Boston Scientific Corporation

USD 102.75

BSX

-0.39 -0.38%

Stryker Corporation

USD 376.67

SYK

-0.91 -0.24%

Medtronic plc

USD 92.74

MDT

-0.14 -0.15%

Zoetis Inc.

USD 149.02

ZTS

+1.67 1.13%

Siemens Healthineers AG

USD 53.31

SHL.DE

-0.75 -1.38%

Becton, Dickinson and Company

USD 192.50

BDX

-1.00 -0.52%

IDEXX Laboratories, Inc.

USD 652.11

IDXX

-5.95 -0.90%

Edwards Lifesciences Corporation

USD 78.16

-0.19 -0.24%

Agilent Technologies, Inc.

USD 114.13

-0.49 -0.43%

DexCom, Inc.

USD 77.85

DXCM

-1.01 -1.28%

Fresenius SE & Co. KGaA

USD 50.88

FRE.DE

-0.04 -0.08%

Terumo Corporation

USD 18.74

4543.T

+0.22 1.21%

View all

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities